Investigator Initiated Clinical Trials
Funds large-scale, non-commercial clinical trials in Denmark to improve patient treatment through innovative medicines, technologies, and procedures, requiring strong scientific quality and public data sharing.
Funder: Novo Nordisk Foundation
Due Dates: August 18, 2026: Full application deadline (call closes) — 14:00 Copenhagen time (CEST)
Funding Amounts: DKK 6–22 million per grant over 3–5 years; total call budget DKK 89 million.
Summary: Supports large-scale, non-commercial clinical trials in Denmark to improve patient treatment through new medicines and technologies, requiring strong scientific quality and public data sharing.
Key Information: Main applicant must be a specialist physician with research leadership, employed at a Danish hospital; grant cannot start until all approvals are in place.
Description
This funding opportunity aims to strengthen the capacity to conduct large-scale, non-commercial clinical trials in Denmark, with the goal of improving patient treatment through the development and evaluation of new medicines, technologies, and clinical procedures. Grants are available for both single-center and multicenter national trials, as well as international trials that are anchored at a Danish hospital. All funded clinical trials must adhere to good clinical practice (GCP), demonstrate strong clinical relevance and scientific quality, and include comprehensive protocols, data management, and statistical analysis plans. A key requirement is that anonymized data from funded trials must be made publicly available after project completion.
